Inventor

FROIMOWITZ MARK

US9 patents

⚠️ This page may combine multiple inventors who share the name “FROIMOWITZ MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHILDRENS MEDICAL CENTER

2 patents

US6028103AFeb 22, 2000

Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation

CHILDRENS MEDICAL CENTER36 citations90

US7531573B2May 12, 2009

Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease

CHILDRENS MEDICAL CENTER0 citations38

BIOFRONTERA BIOSCIENCE GMBH

2 patents

US7060711B2Jun 13, 2006

Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

BIOFRONTERA BIOSCIENCE GMBH24 citations88

US7511064B2Mar 31, 2009

Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

BIOFRONTERA BIOSCIENCE GMBH0 citations48

ALLELIX PHARM ECO L P

2 patents

US6011070AJan 4, 2000

Slow-onset, long-lasting dopamine reuptake blockers

ALLELIX PHARM ECO L P10 citations71

US5821386AOct 13, 1998

Compounds for treating cocaine abuse

ALLELIX PHARM ECO L P2 citations60

RHODE ISLAND EDUCATION

2 patents

US6262064B1Jul 17, 2001

Octahydrobenzo[f]quinoline-based receptor agonists and antagonists

RHODE ISLAND EDUCATION1 citations48

US5863928AJan 26, 1999

Octahydrobenzo f!quinoline-based receptor agonists and antagonists

RHODE ISLAND EDUCATION0 citations48

ION PHARMACEUTICALS INC

1 patent

US6331564B1Dec 18, 2001

Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease

ION PHARMACEUTICALS INC43 citations87